2 Sizable IPOs Price, A Multibillion-Dollar Deal Joins Pipeline, And Anthropic Sets Terms
Renaissance Capital provides pre-IPO research to institutional investors and investment banks. The Firm manages two IPO-focused funds: The Renaissance IPO...
Pipeline
Regeneron Pharmaceuticals, Inc. (REGN) Discusses Factor XI Development Program and Clinical Data in Hematology Pipeline Transcript
Operator Welcome to the Regeneron conference call to discuss its Factor XI development program. My name is Shannon, and I...
Neurocrine Stock: A Buy Amid CNS Pipeline Growth And Ingrezza’s Strength (NASDAQ:NBIX)
This article was written byFollowI'm a biotech and healthcare investment analyst with several years of clinical experience and a Master...
